MSMeenakshi Sharma

Meenakshi Sharma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meenakshi Sharma has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Emerging importance of bio-bank for precision diagnostics and research in neuroinfections – a narrative review

    by Bijyaluxmi N, Srinivasa Sundara Rajan Radhakrishnan, Rosemary Shaji V, Prem Kumar J, Shreya Srinivasan, Thangaraj Lamech, Rajesh Kanna S, Reeta Mani, Meenakshi Sharma, Kanika Vasudeva, et al.

  • Open Access

    Financial Burden, Out-of-Pocket Health Spending, and Household Economic Well-Being in Heart Failure Patients in India: A Multicentre Cross-Sectional Survey

    by Panniyammakal Jeemon, Reethu Salim, K. Safvan, Greeva Philip, Aditya Kapoor, Amir Rashid, Ajay Bahl, Animesh Mishra, Bhavesh Roy, Bishav Mohan, et al.

    Background: Heart failure (HF) is a complex clinical condition requiring resource-intensive management and substantial health expenditure. The adverse economic impact of medical care on patients or financial burden is increasingly recognised as a significant non-clinical entity affecting HF management in low- and middle-income countries (LMIC). We explored the factors associated with Financial Burden (FB) in HF patients in India. Methods: We recruited HF patients from 21 hospitals across India, selected to reflect regional diversity and varying stages of epidemiological transition. Trained personnel collected clinical and economic data using a validated and structured questionnaire. Expenditures were recorded in Indian rupees (INR) and converted to international dollars (INT$). Results: We recruited 1,859 participants. Nearly one-third of participants (30.2%) were women. The mean age was 55.9 (11.3) years, and the mean duration of formal education was 11.3 (3.8) years. Health insurance coverage was reported in one-third (32.2%) of the study population. The average annual out-of-pocket (OOP) expenditure was INR 1,06,566 (INT$ 4,709.10), constituting 92.6% (95% CI: 92.5–92.7) of the total health expenditure. Compared to the previous year, a decline in monthly income was reported by 32.3% of individuals and 36.2% of households. Catastrophic health spending (CHS) and distress financing (DF) were observed in 37.7% (35.5–39.9) and 17.7% (15.9–19.4) of the households, respectively. However, CHS and DF were lower [30.8% (26.2–35.4) and 13.6% (10.2–17.0), respectively] among those with health insurance compared to the uninsured [40.3% (37.6–43.0) and 18.9% (16.7–21.1), respectively]. Conclusion: Seven out of 10 HF patients in India lack financial health protection. OOP expenditures, accounting for over 90% of total health spending, contribute significantly to economic distress in HF patients. Financial burden, affecting more than one-third of HF patients, carries profound implications for individual well-being. Addressing this financial burden, including CHS and DF, is essential for improving clinical outcomes and ensuring health equity.


  • Open Access

    India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022

    by Prabhdeep Kaur, Manikandanesan Sakthivel, Vettrichelvan Venkatasamy, Padmaja Jogewar, Sandeep S. Gill, Abhishek Kunwar, Meenakshi Sharma, Anupam Khungar Pathni, Kiran Durgad, Swagata Kumar Sahoo, et al.

    Background: Hypertension treatment coverage is low in India. A stepwise simple treatment protocol is one of the strategies to improve hypertension treatment in primary care. We estimated the effectiveness of various protocol steps to achieve blood pressure (BP) control in public sector health facilities in Punjab and Maharashtra, India, where the India Hypertension Control Initiative (IHCI) was implemented. Methods: We analyzed the records of people enrolled for hypertension treatment and follow-up under IHCI between January 2018 and December 2021 in public sector primary and secondary care facilities across 23 districts from two states. Each state followed a different treatment protocol. We calculated the proportion with controlled BP at each step of the protocol. We also estimated the mean decline in BP pre- and post-treatment. Results: Of 281,209 patients initiated on amlodipine 5 mg, 159,292 continued on protocol drugs and came for a follow-up visit during the first quarter of 2022. Of 33,450 individuals who came for the follow-up in Punjab and 125,842 in Maharashtra, 70% and 76% had controlled BP, respectively, at the first step with amlodipine 5 mg. In Punjab, at the second step with amlodipine 10 mg, the cumulative BP control increased to 75%. A similar 5% (76%–81%) increase was seen in the second step after adding telmisartan 40 mg in Maharashtra. Overall, the mean (SD) systolic blood pressure (SBP) decreased by 16 mmHg from 148 (15) mmHg at the baseline in Punjab. In Maharashtra, the decline in the mean (SD) SBP was about 15 mmHg from the 144 (18) mmHg baseline. Conclusion: Simple drug- and dose-specific protocols helped achieve a high control rate among patients retained in care under program conditions. We recommend treatment protocols starting with a single low-cost drug and escalating with the same or another antihypertensive drug depending on the cost and availability.


  • Open Access

    Protocol of Process Evaluation of Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT INDIA)Trial

    by Shweta J. Verma, Puja Gulati, Himani Khatter, Deepti Arora, Aneesh Dhasan, Meenakshi Sharma, Padmavathyamma Narayanapillai Sylaja, Jeyaraj D. Pandian

    Background and aims: Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT India) is a complex intervention delivered across 30 centres in 16 Indian states. The study delivers intervention in 12 languages in the form of workbook, videos and short messaging using cellular device and internet as a tool. Objectives of process evaluation are to assess whether trial was implemented as planned (fidelity and dose); whether, how and why the intervention is effective by looking at the stakeholders’ experiences (effectiveness); to assess reach of intervention in population (reach); how intervention fits into treatment plan to cause behavioural change when adopted (adoption); usefulness for target population and bring behaviour change (maintenance). Methods: SPRINT India process evaluation is a prospective, multicentre study conducted with mixed-methods approach. Sample size of centres and stakeholders will be selected by maximum variance purposive sampling strategy. Centres will be stratified primarily for representing the 11 regional language in which the intervention is delivered. Qualitative data will comprise of interviews of patients, care givers and health professionals at these centres using semi structured interview guide. Quantitative data will comprise of all the randomised patients. Process evaluation framework is based on Realist and RE-AIM evaluation models presented according to Medical Research Council’s guidance. The four sections of the framework are context, trial implementation, mechanisms of impact and trial outcomes. Results: Interviews of approximately 100 stakeholders and focus group interviews of health professionals and SPRINT India study central coordinating staff will be conducted. Analysis will be done using triangulation methodology. It will incorporate use of both quantitative and qualitative data, data collection techniques, data sources, evaluation models, stakeholders and researchers. Conclusions: Process evaluation will identify efficacious factors in intervention package and consolidate use of secondary stroke semi-interactive stroke prevention package into practice and policy to prevent recurrent stroke.


  • Implications of bilingualism for neuropsychological evaluation: Insights from a multicentric study from India

    by Faheem Arshad, Suvarna Alladi, Avanthi Paplikar, Meenakshi Sharma, Feba Anna Varghese, Indian Council of Medical Research Neurocognitive Toolbox Consortium

    Background: In the background of linguistic diversity and a large population of bilinguals in India, it is essential to develop standards of neuropsychological testing in the context of bilingualism. Since bilingualism is known to impact specific cognitive processes, there is also the possibility of the need for separate normative data for bilinguals and monolinguals. Towards addressing these gaps, in this large multicentric study from India, bilinguals and monolinguals were evaluated on a comprehensive neuropsychological test battery: the Indian Council of Medical Research‐Neuro Cognitive Tool Box (ICMR‐NCTB).Method: The ICMR‐NCTB that was standardized across five Indian languages was administered to 530 participants: 267 monolingual and 263 bilinguals A systematic method of testing cognition in bilinguals was developed, to identify the appropriate language for testing, ensure language proficiency of examiner, and to interpret the bilingual responses. Additionally, the performance of bilinguals on the ICMR‐NCTB was compared with monolinguals matched for age, education, and gender.Result: Linguistic proficiency of both participants and examiners were determined using validated measures. Cognitive testing in the bilingual context was performed in the most proficient language of the participants, by examiners well versed with the language. Results from the language‐based tests suggested language interference i.e. a frequent occurrence of borrowed‐ and language‐mixed words in responses thereby requiring consideration while scoring. The reported bilingual effect on cognitive processes did not reflect as differences in the performance between bilinguals and monolinguals on any of the standard cognitive tests of attention, executive function, language and visuospatial functions.Conclusion: Observations from the study provide robust recommendations for neuropsychological testing in the context of bilingualism. These recommendations are consistent with the practice of bilingualism in the Indian context and are more ecologically valid. Results also indicate that separate normative data may not be required for bilinguals and monolinguals, in the Indian context. The study will provide a reference framework for comparison to address similar issues in other bilingual societies.


  • Open Access

    Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States—India Hypertension Control Initiative

    by Abhishek Kunwar, Kiran Durgad, Prabhdeep Kaur, Meenakshi Sharma, Leimapokpam Swasticharan, Madhavi Mallela, Ashish Saxena, Sadhana Tayade, Sandeep Gill, Bipin K. Gopal, et al.

    Hypertension is the leading risk factor for cardiovascular disease in India, but less than 10% of the estimated people with hypertension have blood pressure under control. The India Hypertension Control Initiative (IHCI) was implemented to strengthen hypertension management and control in public sector health facilities. Since late March 2020, lockdown due to the COVID-19 pandemic limited healthcare access and disrupted the provision of essential health services. IHCI quickly implemented adaptive interventions to improve access to medications. To estimate the availability of antihypertensive drugs in peripheral public sector facilities during the lockdown and the proportion of patients who received drugs through community drug distribution, i.e., through Health and Wellness Centers (HWCs)/Sub-Centers (SCs), the most peripheral public sector health facilities for primary care, and home delivery. We collected data from 29 IHCI districts of 5 states (Kerala, Madhya Pradesh, Maharashtra, Punjab, and Telangana) during April–May 2020. The population included individuals diagnosed with hypertension and enrolled under IHCI in all public sector primary care health facilities. We contacted a convenience sample of more than one-third of the functional HWC/SC and analyzed the proportion of facilities and patients who received drugs. We also contacted a convenience sample of patients telephonically to estimate their self-reported availability of drugs. Of the 4245 HWC/SC, more than one-third were contacted telephonically, and 85–88% had received antihypertensive medications for community-level distribution. Among 721,675 patients registered until March 2020, 38.4% had received drug refills through HWC/SC or home delivery by frontline workers during the lockdown. We demonstrated the feasibility of community-level drug distribution for patients with hypertension during the COVID-19 lockdown in India. The adaptive strategy of community-based drug distribution through HWC/SC and home delivery appears feasible and may help improve access to hypertension care during the COVID-19 pandemic and beyond.


  • Marriage in people with epilepsy: A compelling theme for psycho-behavioral research

    by Gagandeep Singh, Kalyan K. Ganguly, Manjistha Banerji, Renu Addlakha, Urvashi Shah, Manjari Tripathi, Vinod Saxena, Hitant Vohra, Yashoda Wakankar, Meenakshi Sharma, et al.


  • Open Access

    An information, education and communication module to reduce dietary salt intake and blood pressure among tea garden workers of Assam

    by Prasanta K. Borah, Hem C. Kalita, Suman K. Paine, Purnananda Khaund, Chandra Bhattacharjee, Dilip Hazarika, Meenakshi Sharma, Jagadish Mahanta